MMIT’s Patient Access Analytics

MMIT is a trusted go-to-market partner that identifies barriers to patient access and helps move therapies from pipeline to patient—answering the “what” and “how” of payers covering therapies and the “why” behind those decisions. MMIT offers comprehensive analytics solutions that help pharmaceutical and healthcare companies streamline patient access to treatment. MMIT partners with pharmacy benefit managers (PBMs), payers, and pharmaceutical manufacturers, providing transparency into pharmacy and medical benefit information throughout the drug development process.

A key offering from MMIT is Patient Access Analytics, a solution that integrates a variety of real-world and market access datasets to provide unique insights into payer and prescriber behavior. By combining traditional market access data with real-world data (RWD) from medical and pharmacy claims, lab orders and results, and electronic health records, MMIT’s solution empowers pharmaceutical commercial teams to understand how patients receive care in the real world. Patient Access Analytics distinguishes itself by offering instant answers to questions regarding patient cohort identification, physical prescribing patterns, biomarker testing trends, claims denials, and policy misalignment, among other challenges. This actionable intelligence enables pharma manufacturers to make data-driven decisions to improve patient access to therapies.

In competitive areas like immunology and oncology, MMIT advocates for a holistic approach that augments payer, PBM, and IDN policy, restriction and clinical pathways data with real-world data sets. Pharma manufacturers can then track patient progression along the care continuum and identify opportunities to enhance access. Patient Access Analytics can automate data visualizations and simplify complex data sets on a user-friendly platform. For example, KORU Medical Systems, a medical device company, recently leveraged MMIT’s insights to gain transparency into the reimbursement process for its devices, which enabled KORU to optimize customer conversations, educate prescribers, and align with trends that favored home administration.

MMIT’s streamlined approach removes the burden of data integration, ensuring access barriers are addressed and patients can receive treatment without complications. As life sciences companies increasingly invest in real-world data, Patient Access Analytics offers unmatched data depth and breadth, uncovering a deeper understanding of highly targeted patient populations, prescriber behavior, and provider-payer dynamics.